CTI makes venture capital investments mostly in biotech companies at the pre-clinical and clinical development stages.
CTI Life Sciences, a Canadian venture firm makes venture capital investments in high quality emerging life sciences companies at the pre-clinical and clinical development stage in Canada and in the U.S. CTI Life Sciences currently manage $345 million of assets.